Josh Hoopes Buys 14,861 Shares of ForViva (LON:FVA) Stock

ForViva plc (LON:FVAGet Free Report) insider Josh Hoopes purchased 14,861 shares of the stock in a transaction that occurred on Monday, December 22nd. The shares were acquired at an average price of GBX 134 per share, for a total transaction of £19,913.74.

ForViva Stock Performance

Shares of LON FVA opened at GBX 134 on Thursday. The stock has a market cap of £69.37 million and a PE ratio of -78.82. ForViva plc has a 12-month low of GBX 121 and a 12-month high of GBX 140. The company’s 50-day simple moving average is GBX 131.36.

ForViva (LON:FVAGet Free Report) last released its earnings results on Wednesday, December 10th. The company reported GBX 4.40 earnings per share for the quarter.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group began coverage on shares of ForViva in a report on Monday, October 13th. They issued a “buy” rating and a GBX 170 target price on the stock. One equities research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of GBX 170.

Check Out Our Latest Stock Analysis on FVA

About ForViva

(Get Free Report)

ForViva plc (LON: FVA) is a United Kingdom–based property company that operates in the residential and specialist housing sectors. The group’s activities are focused on ownership, management and leasing of housing assets that serve social, affordable and supported living needs. Its portfolio is oriented toward providing long‑term rental accommodation and specialist premises that accommodate people requiring additional care or support.

Services associated with ForViva’s property portfolio typically include day‑to‑day asset management, tenancy management, property maintenance and refurbishment, and collaboration with public sector bodies and third‑party care providers to deliver supported housing solutions.

Recommended Stories

Receive News & Ratings for ForViva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ForViva and related companies with MarketBeat.com's FREE daily email newsletter.